Details of Metabolite
| Full List of Protein(s) Regulating This Metabolite | ||||||
|---|---|---|---|---|---|---|
| Amino acid/auxin permease (AAAP) | ||||||
| Sodium-coupled neutral amino transporter 10 (SLC38A10) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Overexpression of SLC38A10 | |||||
| Induced Change | D-Aspartic acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that overexpression of SLC38A10 leads to the decrease of D-aspartic acid levels compared with control group. | |||||
| Dicarboxylate/amino acid:cation symporter (DAACS) | ||||||
| Excitatory amino acid transporter 3 (SLC1A1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] | ||||
| Introduced Variation | Overexpression of SLC1A1 | |||||
| Induced Change | D-Aspartic acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Motor neuron disease [ICD-11: 8B60] | |||||
| Details | It is reported that overexpression of SLC1A1 leads to the decrease of D-aspartic acid levels compared with control group. | |||||
| Lyases (EC 4) | ||||||
| Cystathionine gamma-lyase (CTH) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] | ||||
| Introduced Variation | Knockout of Cth | |||||
| Induced Change | D-Aspartic acid concentration: increase (FC = 2.10) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Organic acid disorderss [ICD-11: 5C50] | |||||
| Details | It is reported that knockout of Cth leads to the increase of D-aspartic acid levels compared with control group. | |||||
| Pore-forming PNC peptide (PNC) | ||||||
| Cellular tumor antigen p53 (TP53) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] | ||||
| Introduced Variation | Knockout of TP53 | |||||
| Induced Change | D-Aspartic acid concentration: increase (Log2 FC=1.19) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Colon cancer [ICD-11: 2B90] | |||||
| Details | It is reported that knockout of TP53 leads to the increase of D-aspartic acid levels compared with control group. | |||||
| Transferases (EC 2) | ||||||
| SNF-related serine/threonine-protein kinase (SNRK) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Protein Info
click to show the details of this protein
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[5] | ||||
| Introduced Variation | Knockdown (shRNA) of SNRK | |||||
| Induced Change | D-Aspartic acid concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Healthy individual | |||||
| Details | It is reported that knockdown of SNRK leads to the decrease of D-aspartic acid levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.


